These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30248785)

  • 1. [The favorable effects of KIR3DS1 and Bw4(80Ile) on viral set point and CD4 count decline in HIV-1 patients with acutely infected with HIV-1 infection].
    Wang R; Liu Y; Lu XF; Liu ZY; Li Z; Zhang X
    Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(35):2819-2823. PubMed ID: 30248785
    [No Abstract]   [Full Text] [Related]  

  • 2. Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes.
    Tallon BJ; Bruneau J; Tsoukas CM; Routy JP; Kiani Z; Tan X; Bernard NF
    PLoS One; 2014; 9(10):e110480. PubMed ID: 25330014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in
    Zhang X; Lu X; Moog C; Yuan L; Liu Z; Li Z; Xia W; Zhou Y; Wu H; Zhang T; Su B
    Front Immunol; 2018; 9():1855. PubMed ID: 30147699
    [No Abstract]   [Full Text] [Related]  

  • 4. KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia.
    Marra J; Greene J; Hwang J; Du J; Damon L; Martin T; Venstrom JM
    J Immunol; 2015 May; 194(9):4222-30. PubMed ID: 25810393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective genotypes in HIV infection reflect superior function of KIR3DS1+ over KIR3DL1+ CD8+ T cells.
    Zipperlen K; Gallant M; Stapleton S; Heath J; Barrett L; Grant M
    Immunol Cell Biol; 2015 Jan; 93(1):67-76. PubMed ID: 25112829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors.
    Jiang Y; Chen O; Cui C; Zhao B; Han X; Zhang Z; Liu J; Xu J; Hu Q; Liao C; Shang H
    BMC Infect Dis; 2013 Sep; 13():405. PubMed ID: 24059286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIR3DS1/HLA-B Bw4-80Ile Genotype Is Correlated with the IFN-α Therapy Response in hepatitis B e antigen-Positive Chronic Hepatitis B.
    Li W; Shen X; Fu B; Guo C; Liu Y; Ye Y; Sun R; Li J; Tian Z; Wei H
    Front Immunol; 2017; 8():1285. PubMed ID: 29075265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-Bw4 identifies a population of HIV-infected patients with an increased capacity to control viral replication after structured treatment interruption.
    Stern M; Czaja K; Rauch A; Rickenbach M; Günthard HF; Battegay M; Fellay J; Hirschel B; Hess C;
    HIV Med; 2012 Nov; 13(10):589-95. PubMed ID: 22500819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer KIR3DS1 is closely associated with HCV viral clearance and sustained virological response in HIV/HCV patients.
    Rivero-Juarez A; Gonzalez R; Camacho A; Manzanares-Martin B; Caruz A; Martinez-Peinado A; Torre-Cisneros J; Pineda JA; Peña J; Rivero A
    PLoS One; 2013; 8(4):e61992. PubMed ID: 23613999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells.
    Morvan M; Willem C; Gagne K; Kerdudou N; David G; Sébille V; Folléa G; Bignon JD; Retière C
    J Immunol; 2009 Jun; 182(11):6727-35. PubMed ID: 19454667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putative role of KIR3DL1/3DS1 alleles and HLA-Bw4 ligands with end stage renal disease and long term renal allograft survival.
    Prakash S; Sarangi AN; Alam S; Sonawane A; Sharma RK; Agrawal S
    Gene; 2017 Dec; 637():219-229. PubMed ID: 28942035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIR-HLA-A and B alleles of the Bw4 epitope against HIV infection in discordant heterosexual couples in Chaco Argentina.
    Habegger de Sorrentino A; Sinchi JL; Marinic K; López R; Iliovich E
    Immunology; 2013 Oct; 140(2):273-9. PubMed ID: 23789883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
    Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
    AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1.
    O'Connor GM; Vivian JP; Gostick E; Pymm P; Lafont BA; Price DA; Rossjohn J; Brooks AG; McVicar DW
    J Virol; 2015 May; 89(10):5213-21. PubMed ID: 25740999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Killer Cell Immunoglobulin-Like Receptor Alleles Alter HIV Disease in Children.
    Singh KK; Qin M; Brummel SS; Angelidou K; Trout RN; Fenton T; Spector SA
    PLoS One; 2016; 11(3):e0151364. PubMed ID: 26983081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of KIR3DL1/S1 and HLA-Bw4 with CD4 T cell counts in HIV-infected Mexican mestizos.
    Hernández-Ramírez D; Esparza-Pérez MA; Ramirez-Garcialuna JL; Arguello JR; Mandeville PB; Noyola DE; García-Sepúlveda CA
    Immunogenetics; 2015 Aug; 67(8):413-24. PubMed ID: 26033692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.
    Martin MP; Gao X; Lee JH; Nelson GW; Detels R; Goedert JJ; Buchbinder S; Hoots K; Vlahov D; Trowsdale J; Wilson M; O'Brien SJ; Carrington M
    Nat Genet; 2002 Aug; 31(4):429-34. PubMed ID: 12134147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mind the gap: lack of association between KIR3DL1*004/HLA‐Bw4-induced natural killer cell function and protection from HIV infection.
    Parsons MS; Boulet S; Song R; Bruneau J; Shoukry NH; Routy JP; Tsoukas CM; Bernard NF
    J Infect Dis; 2010 Nov; 202 Suppl 3():S356-60. PubMed ID: 20887224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets.
    Song R; Lisovsky I; Lebouché B; Routy JP; Bruneau J; Bernard NF
    PLoS Pathog; 2014 Jan; 10(1):e1003867. PubMed ID: 24453969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
    O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
    J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.